NCT06986694 Effects of Voodoo Flossing Technique in Knee Osteoarthritis Patients
| NCT ID | NCT06986694 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Knee Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2025-06-12 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2025-06-12 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Knee osteoarthritis (KOA) is a prevalent degenerative joint disease characterized by pain, stiffness, and reduced physical function, significantly impacting quality of life especially in elderly population. This study aims to evaluating the effectiveness of an emerging technique, known as 'Voodoo Flossing' on pain, range of motion and physical function in KOA to provide evidence-based insight of voodoo flossing as a potential therapeutic adjunct in KOA management. This randomized controlled trial will be conducted at Riphah Rehabilitation Clinic, Lahore and Horizon Hospital Lahore in a time span of 8 months. A sample size of 42 subjects selected through non-probability convenient sampling with age group between 45 to 65 having present complain confirmed through Kellgren-Lawrence (KL) scale of grade-II will be divided into two groups, will undergo aerobic exercises, strengthening exercises and conventional physiotherapy protocol either with or without Voodoo Flossing technique.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 45 and ≤ 65 * Both Male and Female * Knee Pain persisting for at-least 3 months * Pain severity during walking ≥ 2/10 on a Numeric Pain Rating Scale * Walking and Balance (Mobility) problems according to Time Up \& Go (TUG) test * Poor scoring on WOMAC scale for pain, stiffness and physical activities * Knee OA Grade II (according to Kellgren-Lawrence method) * Participants must provide informed consent for participation in RCT Exclusion Criteria: * Age \< 45 and \> 65 * Severe Knee pain during Walking ≥ 9/10 on a Numeric Pain Rating Scale * Knee OA Grade I, III \& IV (according to Kellgren-Lawrence method) * Physical or Mental co-morbidity severely affecting daily life of patient * Any Contraindication to provide Exercise Therapy * Suspicion of chronic widespread pain (i.e., pain present for at least 3 months in at least three joints including left and right side of the body, above and below the waist, and the axial skeleton) * Participant undergone total knee arthroplasty or on waiting list for total knee arthroplasty in any knee * Any other reasons for knee pain than knee OA (e.g., rheumatoid arthritis and gout) * Received intraarticular injections in past 6 months because of knee pain (Hyaluronic Gel or steroid)
Contact & Investigator
Hira Shaukat, TDPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06986694 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 65 Years, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06986694 currently recruiting?
Yes, NCT06986694 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06986694 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06986694 clinical trial?
NCT06986694 is sponsored by Riphah International University. The principal investigator is Hira Shaukat, TDPT at Riphah International University. The trial plans to enroll 42 participants.